Akebia Therapeutics | AKBA - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amgen USD 8.62B 1.28B 2026-03
Ardelyx USD 94.47M 30.74M 2026-03
Astellas Pharma JPY 537.93B 33.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 11.44B 1.78B 2025-12
BioMarin Pharmaceutical USD 766M 109M 2026-03
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Exelixis USD 610.8M 12.14M 2026-03
Fresenius Medical Care EUR 4.61B 460M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
J&J USD 24.1B 500M 2026-03
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 389M 289M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pharma Mar EUR 42.9M 47.3M 2026-03
Prothena USD 51.08M 51.06M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03